Handbook of HER2-Targeted Agents in Breast Cancer

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targete...

Full description

Main Authors: Alvarez, Ricardo H. (Author, http://id.loc.gov/vocabulary/relators/aut), Cortés, Javier. (http://id.loc.gov/vocabulary/relators/aut), Falzon, Mary. (http://id.loc.gov/vocabulary/relators/aut), Gandy, Michael. (http://id.loc.gov/vocabulary/relators/aut), Gianni, Luca. (http://id.loc.gov/vocabulary/relators/aut), Harbeck, Nadia. (http://id.loc.gov/vocabulary/relators/aut), Piccart, Martine. (http://id.loc.gov/vocabulary/relators/aut)
Corporate Author: SpringerLink (Online service)
Language:English
Published: Cham : Springer International Publishing : Imprint: Adis, 2016.
Edition:2nd ed. 2016.
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-28216-9
Table of Contents:
  • Introduction and background biology
  • HER2 testing
  • HER2-positive breast cancer: neoadjuvant and adjuvant therapy
  • HER2-positive metastatic breast cancer: first-line treatment
  • HER2-positive metastatic breast cancer: second-line treatment
  • Emerging targeted agents for HER2-positive breast cancer.